The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Electronic Submission of New Drugs in Europe
Abstract
All over the world, drugs and drug applications have to be submitted to and approved by an admission office before they may be sold on the market. All procedures are extensive, time-consuming, and costly. To simplify the process, it could be organised electronically. In an economic perspective, there are many benefits by using the electronic form for the pharmaceutical industry: managing knowledge, cost advantages, and time savings. All, pharmaceutical industry and institutions have undertaken lots of efforts to enforce the electronic solutions. They focus on international standards in order to harmonise structures and processes. It would be necessary to reduce paper and copies, especially if the electronic solution takes place. This method will simplify the way to deal with data and documents and reduce process time and costs.
Related Content
|
Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Ilham Aftais, Fatima Ezzahra Elamrani, Imade Amradi, Adil El Housseini, Youssef Ait Hamdan, Youness Zgandaoui, Abdelghani Iddar, Mohammed El Mzibri, Adnane Moutaouakkil, Aboubaker El Hessni, Abdelhalim Mesfioui.
© 2026.
30 pages.
|
|
Yusuf Olatunji Waidi.
© 2026.
20 pages.
|
|
Ajinkya Nene, Sorour Sadeghzade, Wenjie Yang, Prakash Somani.
© 2026.
12 pages.
|
|
Seyyed Mohammad Amin Mousavi-Sagharchi, Mahdieh Ranjbar-Jamalabadi, Sama Yavari, Elina Afrazeh, Naresh Poondla, Mohsen Sheykhhasan.
© 2026.
32 pages.
|
|
Wenqiang Xie, Yuan Su, Ruiqi Zhang, Sijia Li, Jia Ni, Longquan Shao.
© 2026.
18 pages.
|
|
Zhengao Wang, Huiyu Zhao, Yao Han, Wuyi Zhou, Chengyun Ning.
© 2026.
30 pages.
|
|
Navya Aggarwal, Shinjini Sen, Tanmay J. Urs, Shreya Gupta, Banashree Bondhopadhyay.
© 2026.
36 pages.
|
|
|